June 2025 - Page 10 of 16

WednesdayJun 11, 2025 11:15 am

SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) to Use Net Cash from Geddes Solar Power Project for Bitcoin Purchases

The company’s 3.79 MW Geddes facility is expected to begin generating revenue in June 2025. The initiative marks one of the first integrations of renewable energy and Bitcoin treasury management. Management will determine Bitcoin allocation based on market conditions and operational cash flow. The Geddes site, built on a closed landfill, reflects SolarBank’s dual focus on clean energy and land repurposing. This move could be extended to other solar and battery energy storage projects across the company’s 1+ GW pipeline. Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of…

WednesdayJun 11, 2025 10:38 am

QualityStocksNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Forms Strategic Alliance with Toronto Blizzard to Develop Global Soccer Talent Pipeline

Brera Holdings (NASDAQ: BREA) announced a strategic advisory agreement with Toronto Blizzard Corp., Canada's top soccer scholarship academy, to create a pathway for youth players into professional soccer by linking Blizzard’s development programs with Brera’s multi-club global network. Targeting the $69 billion youth sports and $37 billion sports tourism markets, the initiative aims to develop players ages 3 to 18 through shared coaching methodologies and direct exposure to Brera-affiliated clubs including SS Juve Stabia (Italy), Brera Strumica FC and Brera Tiverija FC (North Macedonia), and others. Talent ID camps and European academy experiences are set to begin in 2026, with…

WednesdayJun 11, 2025 10:30 am

Adageis Allows Healthcare Providers Maximum Value-Based Care Revenue with Simplicity and Visibility

The company offers a simple, AI-powered platform that helps providers identify their most valuable services, bringing clarity to complex insurance contracts, and highlighting where clinics can optimize revenue. The platform’s AI analytics help to identify high-risk patients and close care gaps efficiently, while letting providers track financial performance over time, aligning income with quality of care. Adageis continues to grow and expects to cover 580,000 patient lives by Q2 2025 and reach $100,000 in monthly recurring revenue. As healthcare shifts further toward value-based care, one challenge continues to frustrate providers: understanding how care quality translates into financial outcomes. Adageis, a…

WednesdayJun 11, 2025 9:45 am

Smart Hospitality: SkyTech Robots and the Future of U.S. Service Innovation Through AI

As the world watches Foxconn and NVIDIA deploy smart robotics in Taiwan’s cutting-edge hospitals, the same technology driven future is quietly taking shape across the American hospitality industry. Led by companies like SkyTech Automated Solutions, a wholly owned subsidiary of Nightfood Holdings, Inc. (OTCQB: NGTF). Foxconn's recent unveiling of its NVIDIA-powered hospital robots signals a monumental shift: combining real-time AI with robotics to improve labor efficiency, safety, and service personalization. The smart hospital model represents not just a technological leap, but a redefinition of how service delivery is imagined in labor-intensive environments. SkyTech is bringing that same revolution to the…

WednesdayJun 11, 2025 9:20 am

QualityStocksNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Expands U.S. Forensic Market Presence Through SMARTOX Partnership

Intelligent Bio Solutions (NASDAQ: INBS) reported continued growth in the U.S. Forensic Use Only Market through its strategic alliance with SMARTOX, a Texas-based leader in drug and alcohol screening services. SMARTOX has deployed over 50 INBS Intelligent Fingerprinting Drug Screening Readers and conducted more than 7,000 tests to date—including over 1,500 in 2024—demonstrating rising demand for INBS' rapid, non-invasive testing solution. The technology offers a fingerprint sweat-based alternative to urine and saliva tests, improving efficiency, dignity, and ease of use across corrections, rehabilitation, and drug court environments. INBS is also pursuing FDA clearance for its codeine opiate test, with plans…

WednesdayJun 11, 2025 9:00 am

Lantern Pharma Inc. (NASDAQ: LTRN) Is ‘One to Watch’

Lantern Pharma’s AI-driven RADR(R) platform integrates over 200 billion oncology-specific data points and underpins every stage of its precision oncology pipeline. The company has three lead drug candidates in clinical development, targeting major oncology markets including NSCLC, TNBC, and NHL. Starlight Therapeutics extends Lantern’s footprint into brain and CNS cancers, including pediatric indications supported by orphan and rare disease designations. Lantern has received multiple FDA designations including Fast Track, Orphan Drug, and Rare Pediatric Disease status across its portfolio, enhancing regulatory pathways. With approximately $19.7 million in cash and equivalents, the company is funded through at least mid-2026 to support…

WednesdayJun 11, 2025 9:00 am

QualityStocksNewsBreaks – American Tungsten Corp. (CSE: TUNG) (OTCQB: DEMRF) (FSE: RK9) Publishes NI 43-101 Report and Outlines Summer 2025 Drill Plans for Ima Mine

American Tungsten (CSE: TUNG) (OTCQB: DEMRF) (FSE: RK9) has released its NI 43-101-compliant technical report for the Ima Mine in Idaho and is finalizing the scope and budget for its summer 2025 exploration program. The program will include rehabilitation of the D level to support underground drilling and bulk sampling for metallurgical testwork. Exploration targets include extensions of the No. 5 and No. 7 veins, the southwest continuation of the West Ima vein, the Eastern Vein system, and deeper portions of the main Ima vein, with additional upside potential across Patterson Creek. CEO Ali Haji noted that historical drilling by…

WednesdayJun 11, 2025 9:00 am

QualityStocksNewsBreaks – BluSky AI Inc. (OTC: BSAI) Launches SkyMod Series for Scalable, Rapid-Deploy AI Datacenters

BluSky AI (OTC: BSAI) announced the completion of its modular AI datacenter infrastructure, unveiling the SkyMod series designed for fast deployment in both indoor and outdoor environments. The flagship SkyMod One delivers 1 MW of compute power in a 1,400-square-foot footprint, while the larger SkyMod XL offers 1.7 MW across 3,000 square feet. Each unit integrates NVIDIA GPUs and is fully preassembled, tested, and shipped for plug-and-play activation at client or company sites. Targeted at AI-heavy workloads such as generative AI and large language models, the SkyMod line supports real-time inference and GPU-as-a-service. BluSky AI emphasized sustainability in its design,…

TuesdayJun 10, 2025 3:20 pm

QualityStocksNewsBreaks – Nightfood Holdings Inc. (NGTF): Where Hospitality Meets High Tech

Nightfood Holdings (OTCQB: NGTF) is redefining the hospitality experience by blending artificial intelligence, robotics, and predictive analytics to help hoteliers deliver seamless, personalized service amid labor shortages and rising guest expectations. As one of the few publicly traded companies uniquely positioned at the intersection of hospitality and AI, NGTF offers a compelling investment opportunity. Through its subsidiaries, NGTF provides cutting-edge Robotics-as-a-Service (“RaaS”) solutions and is acquiring hotel properties to serve as live tech showcases. More than a service provider or tech vendor, Nightfood is a catalyst for the next era of hospitality—championing a human-centric, automation-driven future that empowers hotels to thrive.…

TuesdayJun 10, 2025 12:58 pm

QualityStocksNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Taps Biotech Veteran to Lead Next Phase of Growth

Calidi Biotherapeutics (NYSE American: CLDI) recently announced the appointment of Eric Poma, PhD, as its new chief executive officer and member of the board of directors. The company was featured in an article that reads, “As Calidi Biotherapeutics continues to pioneer targeted antitumor virotherapies, the appointment of Dr. Poma as CEO represents a strategic move to harness experienced leadership for the company’s next phase of growth. His extensive background in oncology, successful track record in fundraising and strategic partnerships, and comprehensive understanding of the biotech landscape position him to effectively steer Calidi’s innovative therapies through clinical development and toward commercialization.” To…

Site Search

Company Search

Month: June 2025

SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) to Use Net Cash from Geddes Solar Power Project for Bitcoin Purchases

QualityStocksNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Forms Strategic Alliance with Toronto Blizzard to Develop Global Soccer Talent Pipeline

Adageis Allows Healthcare Providers Maximum Value-Based Care Revenue with Simplicity and Visibility

Smart Hospitality: SkyTech Robots and the Future of U.S. Service Innovation Through AI

QualityStocksNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Expands U.S. Forensic Market Presence Through SMARTOX Partnership

Lantern Pharma Inc. (NASDAQ: LTRN) Is ‘One to Watch’

QualityStocksNewsBreaks – American Tungsten Corp. (CSE: TUNG) (OTCQB: DEMRF) (FSE: RK9) Publishes NI 43-101 Report and Outlines Summer 2025 Drill Plans for Ima Mine

QualityStocksNewsBreaks – BluSky AI Inc. (OTC: BSAI) Launches SkyMod Series for Scalable, Rapid-Deploy AI Datacenters

QualityStocksNewsBreaks – Nightfood Holdings Inc. (NGTF): Where Hospitality Meets High Tech

QualityStocksNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Taps Biotech Veteran to Lead Next Phase of Growth

Market Basics

Newsletter Publishers

Public Companies